Finance

Lists
HQY:NASDAQ
Healthequity Inc
90,19 US$
-2,00%
(-1,84) 1D
90,19 US$
0,00% (0,00)
After hours
Closed: 13 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HQY...
Open
92,43 US$
High
92,72 US$
Low
89,92 US$
Mkt. cap
7,46 მლრდ.
Avg. vol.
855,15 ათ.
Volume
0,00
P/E ratio
32,59
52-wk high
107,62 US$
52-wk low
72,76 US$
EPS
2,77 US$
Beta
0,24
Shares outstanding
82,72 მლნ.
No. of employees
3 ათ.
Open
92,43 US$
High
92,72 US$
Low
89,92 US$
Mkt. cap
7,46 მლრდ.
Avg. vol.
855,15 ათ.
Volume
0,00
P/E ratio
32,59
52-wk high
107,62 US$
52-wk low
72,76 US$
EPS
2,77 US$
Beta
0,24
Shares outstanding
82,72 მლნ.
No. of employees
3 ათ.
News stories
From web sources and news partners
StreetInsider
StreetInsider
·
19 საათის წინ
Jefferies examines HealthEquity stock short interest rise
Profile
HealthEquity, Inc. is an American financial technology and business services company that is designated as a non-bank health savings trustee by the IRS. This designation allows HealthEquity to be the custodian of health savings accounts regardless of which financial institution the funds are deposited with. As of July 31, 2022, HealthEquity managed 7.5 million HSA accounts, plus 7 million other consumer-directed benefits for total accounts of 14.5 million. Total HSA assets as of July 31, 2022 were $20.5 billion, including $13.1 billion of HSA cash and $7.4 billion of HSA investments. Wikipedia
About Healthequity Inc
CEOჯონ კესლერ
Employees2,81 ათ.
Founded1 იან. 2002
HeadquartersDraper, იუტა, ამერიკის შეერთებული შტატები
SectorHealth care provider
Analyst ratings
Based on 9 analysts giving stock ratings to HQY in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for HQY in the last 3 months.
Highest
Current 90,19 US$
142,00 US$ (+57,45%)
Average
118,89 US$ (+31,82%)
Lowest
105,00 US$ (+16,42%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Halsted
RBC Capital
Buy
Maintained
108,00 US$
+19,7%
10/06/2026
Stan Berenshteyn
Wells Fargo
Buy
Reiterated
125,00 US$
+38,6%
09/29/2026
Peter Warendorf
Barclays
Buy
Reiterated
115,00 US$
+27,5%
09/18/2026
George Hill
Deutsche Bank
Buy
Reiterated
142,00 US$
+57,4%
08/31/2026
Alexander Paris
Barrington
Buy
Reiterated
110,00 US$
+22%
08/28/2026
Sean Dodge
BMO Capital
Buy
Maintained
105,00 US$
+16,4%
08/28/2026
David Larsen
BTIG
Buy
Maintained
115,00 US$
+27,5%
08/28/2026
Allen Lutz
Bank of America Securities
Buy
Reiterated
125,00 US$
+38,6%
08/28/2026
Scott Schoenhaus
KeyBanc
Buy
Maintained
125,00 US$
+38,6%
08/18/2026
Alexei Gogolev
J.P. Morgan
Buy
Reiterated
123,00 US$
+36,4%
06/25/2026
Constantine Davides
Citizens JMP
Buy
Maintained
111,00 US$
+23,1%
06/01/2026
David Roman
Goldman Sachs
Sell
Maintained
88,00 US$
-2,4%
05/29/2026
Daniel Perlin
RBC Capital
Buy
Reiterated
100,00 US$
+10,9%
03/17/2026
Brian Tanquilut
Jefferies
Buy
Maintained
108,00 US$
+19,7%
02/19/2026
Gregory Peters
Raymond James
Buy
Reiterated
100,00 US$
+10,9%
02/17/2026
Last report
27 აგვ. 2026
Fiscal period
Q2 2027
1,24 US$ / 1,19 US$
+3,91%beat
Revenue / Est. (USD)
350,73 მლნ. / 349,23 მლნ.
+0,43%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ოქტ. 2025
იან. 2026
აპრ. 2026
ივლ. 2026
Revenue
322,16 მლნ.
334,59 მლნ.
354,64 მლნ.
350,73 მლნ.
Cost of goods sold
94,10 მლნ.
106,44 მლნ.
98,33 მლნ.
92,78 მლნ.
Cost of revenue
94,10 მლნ.
106,44 მლნ.
98,33 მლნ.
92,78 მლნ.
Research and development expenses
65,92 მლნ.
70,35 მლნ.
67,77 მლნ.
73,92 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55,29 მლნ.
58,45 მლნ.
57,96 მლნ.
58,08 მლნ.
Operating expense
148,21 მლნ.
155,75 მლნ.
152,25 მლნ.
158,29 მლნ.
Total operating expenses
242,31 მლნ.
262,19 მლნ.
250,58 მლნ.
251,07 მლნ.
Operating income
79,85 მლნ.
72,40 მლნ.
104,07 მლნ.
99,66 მლნ.
Other non operating income
22,00 ათ.
329,00 ათ.
161,00 ათ.
20,00 ათ.
EBT including unusual items
67,53 მლნ.
60,90 მლნ.
92,41 მლნ.
87,86 მლნ.
EBT excluding unusual items
68,69 მლნ.
62,22 მლნ.
93,53 მლნ.
88,84 მლნ.
Income tax expense
15,84 მლნ.
11,16 მლნ.
23,00 მლნ.
22,22 მლნ.
Effective tax rate
23,46%
18,32%
24,88%
25,29%
Other operating expenses
-
-
-
-
Net income
51,69 მლნ.
49,74 მლნ.
69,42 მლნ.
65,64 მლნ.
Net profit margin
16,05%
14,87%
19,57%
18,72%
Earnings per share
1,01
0,95
1,24
1,24
Interest and investment income
2,86 მლნ.
2,77 მლნ.
1,89 მლნ.
1,76 მლნ.
Interest expense
-14,05 მლნ.
-13,27 მლნ.
-12,59 მლნ.
-12,60 მლნ.
Net interest expenses
-11,18 მლნ.
-10,50 მლნ.
-10,70 მლნ.
-10,84 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
118,63 მლნ.
111,08 მლნ.
142,28 მლნ.
141,62 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები